ARCHIVES

Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL

This article is from The Cancer Letter archive.

Vol. 21 No. 17 | April 28, 1995

Download PDF Visit The Full Archive

Related Articles

House, Senate Must Resolve Major Differences In Authorization Bills

September 12, 1980

Facing Congressional Criticism, NIH Starts Review of Extramural Conflict Policies.

June 13, 2008

Abstracts of ‘Most Newsworthy’ Papers

June 3, 1977

Alimta Granted Approval As NSCLC Continuation Therapy

November 25, 2011

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010

Two Phase II Trials Display Ramucirumab Potential Efficacy

October 26, 2012